Lilly takes on Pfizer, Novartis with new breast cancer drug data Ruby Khatun Khatun12 Sept 2017 10:01 AM ISTNEW YORK/MADRID: Eli Lilly staked its claim for a slice of sales in a new class of breast cancer drugs on Sunday as clinical data showed adding its...
After melanoma surgery, Bristols Opdivo offers new care standard Ruby Khatun Khatun12 Sept 2017 9:15 AM ISTMADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 1:05 PM ISTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...
Google bets on European biotech drugs, backs new fund Ruby Khatun Khatun19 Jun 2017 9:26 AM ISTLONDON: Google is betting on the potential of European biotech companies to deliver life-changing drugs by investing alongside Swiss company Novartis...
Kieran Murphy appointed as president and CEO of GE Healthcare Ruby Khatun Khatun13 Jun 2017 12:14 PM ISTBOSTON: GE Chairman and CEO Jeff Immelt announced the appointment of Kieran Murphy as president and CEO of GE Healthcare, effective immediately.Murphy...
Novartis, Abbott, Emcure face allegations of cartelisation in anti-diabetes drug Vildagliptin savita thakur thakur26 March 2017 11:33 AM ISTThe Swiss drug maker Novartis and US based Abbott along with domestic companies Emcure and USV Pharma are under the lens of Health Ministry and...
